Showing results (2631-2640 of 2,941) with videos related to
Sort By:
Pageof 295
Cancer Investigation|January 24, 2020
Ras-Mediated Activation of NF-κB and DNA Damage Response in CarcinogenesisAnas Ahmad, Haseeb AhsanCancer Investigation|September 16, 2020
DNA Methylation and Gene Expression with Clinical Covariates Explain Variation in Aggressiveness and Survival of Pancreatic Cancer PatientsShyamali Mukerjee, Agustin Gonzalez-Reymundez, Sophia Y Lunt, et al.Cancer Investigation|April 9, 2004
Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient managementLawrence R Kleinberg, Jon Weingart, Peter Burger, et al.Cancer Investigation|April 9, 2004
Action of troxacitabine on cells transduced with human cytidine deaminase cDNAAnne-Julie Boivin, Henriette Gourdeau, Richard L MomparlerCancer Investigation|April 9, 2004
Physical activity interventions in the elderly: cancer and comorbidityFrank J Penedo, Neil Schneiderman, Jason R Dahn, et al.Cancer Investigation|April 9, 2004
National Institutes of Health's Clinical Center sets new policy on use of herbal and other alternative supplements by patients enrolled in clinical trialsAndrew Sparber, Denise Ford, Patricia A KvochakCancer Investigation|December 8, 2004
Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neuHoward Safran, David Iannitti, Ramesh Ramanathan, et al.Cancer Investigation|December 8, 2004
Differential effects of antiangiogenic compounds in neovascularization, leukocyte recruitment, VEGF production, and tumor growth in miceAndrezza V Belo, Lucíola S Barcelos, Mauro M Teixeira, et al.Cancer Investigation|March 23, 2005
Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanomaLynn Feun, Angela Marini, Frederick Moffat, et al.Cancer Investigation|March 23, 2005
Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II studyNikolaos Androulakis, Konstantinos Syrigos, Aristidis Polyzos, et al.Pageof 295